RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION

Clinical trials for RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION explained in plain language.

Never miss a new study

Get alerted when new RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION trials appear

Sign up with your email to follow new studies for RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Heart failure drug shows promise in extended safety trial

Disease control Completed

This study looked at the safety of a drug called levosimendan when used for a longer time in people who have both pulmonary hypertension and a type of heart failure where the heart pumps normally but is stiff (HFpEF). 35 patients who had already been in a previous study received …

Matched conditions: RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION

Phase: PHASE2 • Sponsor: Tenax Therapeutics, Inc. • Aim: Disease control

Last updated May 13, 2026 15:59 UTC

RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION

Get alerted when new RIGHT SIDED HEART FAILURE WITH NORMAL EJECTION FRACTION trials appear

Heart failure drug shows promise in extended safety trial